Company intelligence / Profile preview

Astel Medica

Tinlot, Wallonia, Belgiumastel-medica.com ↗

Ownership: Private
Employees: ~32
Development stage: Other

Overview

Astel Medica is a Belgian pharmaceutical company specializing in the development and manufacturing of innovative, evidence-based symbiotics and probiotics. The company collaborates with several universities to advance research and provide high-quality probiotic products for various therapeutic areas including gynecology, immunology, pediatrics, and cardiology. It has over 20 years of experience in live bacteria-based products.

Therapeutic areas: ImmunologyCardiovascularWomen's HealthOther
Modalities: ProbioticsLive biotherapeutic product therapySmall molecule
Industry: Biotech

Drug pipeline

8 assets

Bactecal D

Preclinical

7 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with at least 7 universities; no major pharma partnerships specifically named.

Beyond the preview

Go deeper on Astel Medica.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Astel Medica.

Explore the full profile